To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Neuraptive appoints Radie as CEO
Neuraptive Therapeutics Inc, a developer of new treatments for peripheral nerve injuries, has named Robert S. Radie as CEO.
